Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase

Kidney International

Volumn 52, Issue 3, 1997, Pages 742-747

  Eklöf, Ann Christine ^a   Holtbäck, Ulla ^a   Sundelöf, Martin ^a   Chen, Shanlin ^a   Aperia, Anita ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Dopamine; Glu dopa; Natriuresis; Nitecapone; Proximal tubular cells; Sodium potassium ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATECHOL METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY PROXIMAL TUBULE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION;

EID: 0030769302     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.390     Document Type: Article

References (34)

1. LEE MR: Dopamine and the kidney: Ten years on. Clin Sci 84:357-375, 1993
2. LEE MR: Dopamine and the kidney, in Advances in Renal Physiology, edited by LOTE CJ, London and Sydney, Croom Helm, 1986, pp 218-246
3. CUCHE JL, KUCHEL O, BARBEAU A, BOUCHER R, GENEST J: Relationship between the adrenergic nervous system and renin during adaptation to upright posture: A possible role for 3,4-dihydroxyphenylalanine (dopamine). Clin Sci 43:481-491, 1972
4. ALEXANDER RW, GILL GR JR, YAMABE M, LOVENBERG W, KEISER HR: Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest 54:194-200, 1974
5. BAINES AD, CHAN W: Production of free dopamine from DOPA: A micropuncture study. Life Sci 10:253-259, 1980
6. CAREY RM, VAN LOON GR, BAINES AD, ORTT EM: Decreased plasma and urinary dopamine during dietary sodium depletion in man. J Clin Endocrinol Metab 52:903-909, 1981
7. BALL SG, LEE MR: The effects of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol 4:115-119, 1977
8. +-ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am J Physiol 254:F795-F801, 1988
9. HAGEGE J, RICHET G: Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int 27:3-8, 1985
10. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252:F39-F45, 1987
11. WORTH DP, HARVEY JN, BROWN, WORRAL A, LEE MR: Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous γ-L-glutamyl-L-dopa. Br J Clin Pharmac 21:497-502, 1986
12. FERNANDES MH, SOARES DA SILVA P: Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney. J Pharmacy Exp Ther 255:1309-1313, 1990
13. FERNANDES MH, PESTANA M, SOARES DA SILVA P: Deamination of newly formed dopamine in rat renal tissues. Br J Pharmacol 102:778-782, 1991
14. FERNANDES MH, SOARES DA SILVA P: Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J Neural Transm Suppl 41:101-105, 1994
15. KOPIN IJ: Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37:333-364, 1985
16. MEISTER B, BEAN AJ, APERIA A: Catecholamine-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Kidney Int 44:726-733, 1993
17. NISSINEN E, LINDÉN IB, SCHULTZ E, KAKKOLA S, MÄNNISTÖ PT, POHTO P: Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Eur J Pharmacol 153:263-269, 1988
18. MÄNNISTÖ PT, ULMANEN I, LUNDSTROM K, TASKINEN J, TENHUNEN J, TILGMANN C, KAKKOLA S: Characteristics of catechol-O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res 39:291-350, 1992
19. WILK S, MIZOGUCHI H, ORLOWSKI M: γ-glutamyl dopa: A kidney-specific dopamine precursor. J Pharmacol 206:227-232, 1978
20. NISSINEN E, MÄNNISTÖ P: Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. Anal Biochem 137:69-73, 1984
21. EKLÖF A-C, APERIA A: Renal function in different forms of renovascular hypertension in rats. Acta Physiol Scand 136:487-492, 1989
22. HILGER HH, KLUMPER JD, ULLRICH KJ: Wasserruckresorption und ionentransport durch die sammeltrohrzellen der Säugetierniere. Pfluger Arch Gesamt Physiol 267:218-229, 1958
23. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21:767-771, 1993
24. +-ATPase activity in rat proximal tubule after high protein diet. Acta Physiol Scand 139:9-13, 1990
25. HAYASHI M, YAMAJI Y, KITAJIMA W, SARUTA T: Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 258:F28-F33, 1990
26. CARAMONA MM, SOARES-DA-SILVA P: Evidence for an extraneural location of monoamine oxidase in renal tissues. Naunyn Schmiedebergs Arch Pharmacol 341:411-413, 1990
27. FERNANDES MH, SOARES-DA-SILVA P: Type A and B monoamino oxidase activities in the human and rat kidney. Acta Physiol Scand 145:363-367, 1992
28. AXELROD J, ALBERS WW, CLEMENTE CD: Distribution of catecholO-methyltransferase in the nervous system and in other tissues. J Neurochem 5:68-71, 1959
29. KARHUNEN T, TILGMANN C, ULMANEN I, JULKUNEN I, PANULA P: Distribution of catechol-O-methyltransferase enzyme in rat tissues. J Histochem Cytochem 42:1079-1090, 1994
30. GULDBERG HC, MARSDEN CA: Catechol-O-methyltransferase: Pharmacological aspects and physiological role. Pharmacol Rev 27:135-206, 1975
31. GORDONSMITH RH, RAXWORTHY MJ, GULLIVER PA: Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivates and α-substituted catecholamines. Biochem Pharmacol 31:433-437, 1982
32. IMURA O, SHIMAMOTO K: Suppressed dopaminergic activity and water-sodium handling in kidneys at the prehypertensive stage of essential hypertension. J Auton Pharmacol 10(Suppl 1):S73-S77, 1990
33. YOSHIMURA M, KOMORI T, NISHIMURA M, HABUCHI Y, FUJITA N, NAKANISHI T, YASUMURA T, TAKANASHI H: Diagnostic significance of dopamine estimation using plasma and urine in patients with adrenal and renal insufficiency, renal transplantation and hypertension. Hypertens Res 18(Suppl 1):S87-S92, 1995
34. KUCHEL O, SHIGETOMI S: Dopamine deficiency - Its potential contribution to chronic renal failure complicating hypertension. Hypertens Res 18(Suppl 1):S183-S185, 1995